Sukhi Jagpal - 08 Aug 2024 Form 4 Insider Report for SUTRO BIOPHARMA, INC. (STRO)

Role
Director
Signature
/s/ Edward C. Albini as attorney-in-fact for Sukhi Jagpal
Issuer symbol
STRO
Transactions as of
08 Aug 2024
Net transactions value
$0
Form type
4
Filing time
12 Aug 2024, 16:40:20 UTC
Previous filing
01 Jul 2022
Next filing
10 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STRO Stock Option (Right to Buy) Award $0 +35,000 $0.000000 35,000 08 Aug 2024 Common Stock 35,000 $3.22 Direct F1
transaction STRO Stock Option (Right to Buy) Award $0 +28,959 $0.000000 28,959 08 Aug 2024 Common Stock 28,959 $3.22 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 2.778% of the total award monthly, beginning on September 8, 2024, with 100% of the award being vested and exercisable on August 8, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.
F2 The option vests as to 10.07% of the total award monthly beginning on September 8, 2024 through May 8, 2025, and 9.38% shall vest on June 6, 2025, with 100% of the award being vested and exercisable on the date of the issuer's 2025 annual meeting of its stockholders, subject to the reporting person's provision of service to the issuer on each vesting date.